Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2022 |
Nov. 30, 2021 |
Nov. 30, 2022 |
Nov. 30, 2021 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||
| Revenue | $ 24,924 | $ 0 | $ 160,352 | $ 0 |
| Expenses | ||||
| Research and development (Note 15) | 4,581,552 | 6,835,304 | 15,133,191 | 20,757,937 |
| General and administrative (Note 16) | 3,182,927 | 3,091,255 | 18,230,255 | 9,368,052 |
| Gain on disposition of assets (Note 6) | (6,703,558) | 0 | (6,703,558) | 0 |
| Depreciation and amortization (Notes 7 and 8) | 133,902 | 135,035 | 410,544 | 407,806 |
| Interest and other financial expenses (Note 20) | 54,402 | 49,655 | 138,962 | 113,344 |
| Interest income | (13,315) | (23,654) | (35,842) | (41,828) |
| Foreign exchange loss (gain) | (197,913) | 10,648 | (289,022) | 42,712 |
| Total expenses | 1,037,997 | 10,098,243 | 26,884,530 | 30,648,023 |
| Net Loss | (1,013,073) | (10,098,243) | (26,724,178) | (30,648,023) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustment | (439,297) | (13,473) | (856,567) | (160,371) |
| Comprehensive income (loss) | $ (1,452,370) | $ (10,111,716) | $ (27,580,745) | $ (30,808,394) |
| Loss per share | ||||
| Basic and Diluted | $ (0.02) | $ (0.21) | $ (0.56) | $ (0.69) |
| Weighted average common shares outstanding | ||||
| Basic and Diluted | 47,416,340 | 47,264,646 | 47,405,801 | 44,600,557 |